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INTRODUCTION AND OBJECTIVES 
 
Glycomacropeptide (GMP) has a MW of ca. 8000 Da and 
has been proven to possess beneficial bioactive roles 
which include induction of satiety by stimulation of 
cholecystokinin release from intestinal cells (Keogh 
2010), inhibition of platelet aggregation, support of bene-
ficial intestinal LAB, ability to bind cholera and E. coli 
enterotoxins, inhibition of bacterial and viral adhesions, 
modulation of immune system responses, (Bezkorovainy 
1979; Azuma 1984; Thomä-Worringer 2006), and reduc-
tion of dental caries (Schaafsma 2000; Aimutis 2004; 
Janer 2004). As most proteins, GMP is fragile and even 
small conformational changes may reduce its biological 
activity. The development of strategies that may permit 
structural and functional stabilization of GMP via 
nanoencapsulation may increase its applicability in the 
food and biopharmaceutical industries (Srinivas 2010), 
by protecting the bioactive peptide from denaturation by 
proteolysis and dilution effects. Recently, the stabiliza-
tion of proteins and enzymes based on nanoencapsulation 
procedures has started to gain momentum, based on en-
capsulation of such macromolecules in a nanoemulsion 
matrix (Ragoonanan 2007; Rawat 2008) with an hydro-
philic core: similarly to the stabilization mechanism of 
osmolytes, in nanoencapsulation the water activity is al-
tered thus affecting the molecular motions of the proteins. 
Therefore, nanosized vesicles with an hydrophilic core 
may significantly increase the structural and functional 
stability of bioactive proteins for applications in the food 
and biopharmaceutical sectors. In this context, water-in-
oil-in-water (W/O/W) (nano)emulsions, which are exam-
ples of multiple emulsions in which dispersions of small 
water droplets within larger oil droplets are themselves 
dispersed in a continuous (external) aqueous phase 
(Bibette 1999; Ficheux 1998; García-Fuentes 2002; 
Wang 2006; Hanson 2008; Dupeyrón 2009) have been 
proven to be suitable carriers for the simultaneous en-
trapment-stabilization of bioactive lactoferrin (Costa 
2010). Nanosized emulsions are a class of stable emul-
sions composed of surfactant and oil suspended in water, 
which (reported) stability makes them extraordinary and 
often described as “approaching thermodynamic sta-
bility” (Kotyla 2008; Gutiérrez 2008). Oral delivery of 
(bioactive) proteins has been long identified as one of the 
main challenges in drug delivery science and 
(bio)technology. Nanoemulsions (NE), being non-
equilibrium systems with a spontaneous tendency to 
separate into the constituent phases, may possess how-
ever a relatively high kinetic stability, even for several 
years (Gutiérrez 2008). Nano-emulsions are non-
equilibrium systems, and so energy input, generally from 
mechanical devices or from the chemical potential of the 
components, is required for their formation. In the pres-
ent research work, bovine GMP was entrapped in the hy-
drophilic core contained within lipid nanovesicles, inte-
grating W/O/W multiple NE, aiming at mimicking the 
multifunctional design of biological membranes, with 
several lipid matrices, and stabilizing layer compositions, 
with the ultimate goal of achieving its structural and 
functional stabilization. Due to their compartimentalized 
internal structure, multiple emulsions present advantages 
over simple O/W emulsions for encapsulation, such as 
the ability to carry both polar and non-polar molecules, 
and a better control over releasing of therapeutic mol-
ecules (Pays 2002; Davis 1987; Hanson 2008). 
 
MATERIALS AND METHODS 
 
Preparation of multiple GMP-encasing NE. 
Production of multiple W/O/W NE with nanoencapsu-
lated GMP was carried out in an UltraTurrax (T25D from 
IKA) under heating (ca 38 °C), with the bioactive GMP 
being previously dissolved in the (inner) aqueous phase 
(W) prior to being dispersed in the melted lipid (Softisan, 
from Sasol) during homogenization (10 min at 8000 rpm 
or 10000 rpm). Therefore, final W/O/W dispersion of 
GMP was obtained via a sequential (optimized) ho-
mogenization of a W/O dispersion involving two cycles 
for 10 min. The inner aqueous phase was constituted by 
HCl 10 mM, CaCl2 20 mM, Tween 80 and pure bovine 
GMP (from Davisco Foods); the intermediate oily phase 
encompassed glycerol, Softisan 100 and soybean phos-
phatidylcholine; finally, the outer aqueous phase encom-
passed Lutrol 68 (poloxamer 188 from BASF), ultrapure 
water and NaCl 10 mM. GMP-encasing nanovesicles 
were stored throughout 160 days under refrigerating con-
ditions. 
 
Evaluation of the combined effects of homogenization 
speed, GMP concentration and ionic strength of the 
inner aqueous phase for optimization of the nanofor-
mulation (NF). 
The combined effects of homogenization speed, GMP 
concentration and ionic strength of the inner aqueous 
phase were studied by producing emulsions at different 
homogenization speeds (from 8000 to 10000 rpm), with a 
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constant amount of GMP (50 mg) and ionic strengths 
(CaCl2 0.001 M, HCl 0.01 M) of the inner aqueous phase. 
 
Determination of hydrodynamic size (HS) and Zeta po-
tential (ZP). 
The ZP and HS of the nanoemulsion particles were de-
termined in a Zetasizer (model Nanoseries Nano-ZS) 
from Malvern Instruments. 
 
RESULTS AND DISCUSSION 
 
The mean size and size distribution (polydispersity index) 
were measured via Dynamic Laser Light Scattering. Buf-
fered GMP was found to be more stable than unbuffered, 
purified GMP. Optimum homogenization time was found 
to be 10 min at 10000 rpm, since during such timeframe 
particle size was maintained at values ranging from 100 – 
400 nm. Addition of an electrolyte (calcium chloride 
0.001 M) to the inner aqueous phase proved to be most 
suitable by producing nanovesicles with a stable ZP (of 
ca. -10 mV) throughout storage time. However, when 
using a higher (0.1 M) electrolyte concentration, phase 
separation was notorious immediately after homogeniza-
tion which can be correlated with the higher (stable and 
close to zero) values of ZP produced. Decreasing electro-
lyte concentration led to lower (more negative) and more 
stable values of ZP, since the electric charge of κ-casein 
GMP is highly negative in comparison with other milk 
proteins. Storage of the optimized multiple NE through-
out 131 d at fridge temperature did not lead to observable 





A lipid with mild melting temperature was found most 
appropriate for the discontinuous oily phase. A homoge-
neization timeframe of 10 min, the use of an electrolyte 
with a low ionic strength, and an amount of GMP of 50 
mg were found to be critical variables for producing sta-
ble nanovesicle dispersions with diameters ranging from 
100-400 nm and ZP values of ca. -10 mV. The use of 
these multiple NE in formulating functional (bioactive) 
food formulations would possess inherent advantages due 
to the bioactivity of the naturally-occurring GMP, duly 
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